Here are three things to know:
1. Through its collaboration with CLS, MRI Interventions President and CEO Joe Burnett said the company can move into the minimally invasive neurosurgery space with its new navigation and laser ablation therapy offerings.
2. Mr. Burnett estimates the formal launch of the combined platform will occur in 2020.
3. CLS currently has FDA clearance for its Thermal Therapy System, a laser system for soft tissue ablation.
More articles on devices:
Retaliation lawsuit against Stryker & former employee is revived
Zimmer Biomet, Apple to launch joint replacement app: 4 things to know
Current use of contaminated pedicle screws & required practice for asepsis in spine surgery — 2 Qs with Dr. Aakash Agarwal
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
